The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human (FIH) trial evaluating immune activation and safety of PIN- 2 administered intravenously to patients with advanced solid tumors.
 
Colin Bier
Employment - ABA BioResearch; PIN Pharma
Leadership - ABA BioResearch; PIN Pharma
Stock and Other Ownership Interests - PIN Pharma
Consulting or Advisory Role - IntraBio; PIN Pharma; X4 Pharma
Patents, Royalties, Other Intellectual Property - PIN Pharma
 
Michael Millward
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pfizer/EMD Serono; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
 
Dusan Kotasek
No Relationships to Disclose
 
Kenneth J Gorelick
Employment - Zymo Consulting Group
Leadership - PIN Pharma; X4 Pharma; Zymo Consulting Group
Stock and Other Ownership Interests - X4 Pharma
Consulting or Advisory Role - ICON Clinical Research; IntraBio; Neurotrope; Pfizer; PIN Pharma; Shire Human Genetic Therapies; X4 Pharma
Other Relationship - NGN Capital LLC
 
Joshua Brian Goldberg
Employment - PIN Pharma
Stock and Other Ownership Interests - PIN Pharma
Research Funding - PIN Pharma
Patents, Royalties, Other Intellectual Property - PIN Pharma
Travel, Accommodations, Expenses - PIN Pharma